Featured
Last news
'Mass casualty' quake rocks Myanmar, Thailand
A powerful earthquake hit Myanmar and neighbouring Thailand on Friday, turning a major hospital in the Myanmar capital into a "mass casualty area" and trapping dozens of workers in an under-construction skyscraper in Bangkok.
Duterte supporters rally as ex-Philippine leader marks 80th in jail
Family and supporters of former Philippine president Rodrigo Duterte rallied Friday to mark his 80th birthday and protest against his detention in The Hague on a charge of crimes against humanity.
Powerful earthquake rocks Myanmar, Thailand
A powerful earthquake rocked central Myanmar on Friday, buckling roads in capital Naypyidaw, damaging buildings and forcing people to flee into the streets in neighbouring Thailand.
South Korea's 'heartbreaking' wildfires expose super-aged society
Walking with a cane, 84-year-old apple farmer Kim Mi-ja surveys the wreckage of her village, which was reduced to rubble and covered in ash by South Korea's worst wildfires.
Australian cop spared prison after fatal tasering of 95-year-old
An Australian judge sentenced a policeman who fatally tasered a "frail and confused" 95-year-old woman to do community service rather than jail time.
Family fights for death-row retrial under Japan's 'snail-paced' system
Since his teenage years, Koji Hayashi has dreaded one thing: his stubborn, once-vivacious mother being hanged for murder after failing to win her long campaign for a retrial.
South Korea's life game 'InZOI' challenges 'The Sims'
South Korean game publisher Krafton released early access to its life simulation game "InZOI" Friday, hoping its powerful lifelike graphics will unseat the decades-long dominance of "The Sims" hit franchise.
Man charged with destroying Teslas in Las Vegas, amid anti-Musk wave
A man who allegedly set fire to five Teslas and sprayed them with bullets from a semi-automatic rifle appeared in a US court Thursday to face federal arson charges, the Department of Justice said.
Genflow Biosciences PLC Announces Director Dealings
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Genflow Biosciences PLC Announces Holding in Company
LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 / 1. Issuer Details
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes
Two of LQR House Stockholders, Including Its CEO, Enter Lock-up Agreement Covering at Least 209,543 Shares
MIAMI BEACH, FL / ACCESS Newswire / March 28, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that two of its stockholders, including its Chief Executive Officer, signed 12-month lock-up agreements, covering 209,543 shares of the Company's common stock that they now own and any future shares of common stock they may acquire during 12 months lock-up period. Currently this represents approximately 0.6% of LQR House's outstanding shares. Both agreements restrict the sale of shares and other securities that can be acquired by these stockholders for 12 months, i.e. until January and March 2026 respectively.
UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine
VANCOUVER, BC / ACCESS Newswire / March 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), announces that, further to its news release dated March 19, 2025, it has closed the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD").
83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Canalevia®-CA1 (crofelemer delayed-release tablets) is the first and only treatment for CID in dogs to receive any type of approval from the FDAIn dogs undergoing chemotherapy, as is the case with people undergoing cancer treatment, diarrhea is a highly neglected and unmet medical need
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Completion of unbuzzdTM Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company's Pipeline of Products and Assets
Juan Ardila: Bringing Government to the People with Mobile Office Hours
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / In an era where many elected officials are criticized for being out of touch with their constituents, Juan Ardila set out to change that. As an Assemblyman for Western Queens, he prioritized accessibility, launching mobile office hours to meet with residents across the district. Instead of requiring people to travel to a central office, Ardila and his team brought government services directly to the community.
Judge hears Associated Press suit over White House denial of access
Lawyers for the Associated Press (AP) urged a federal judge on Thursday to restore the news agency's reporters access to the White House press pool that covers US President Donald Trump's events.
Games publisher Ubisoft announces restructuring, billion-euro investment
In a bid to escape financial woes, French games giant Ubisoft said Thursday it was creating a new subsidiary around its most popular franchises such as "Assassin's Creed" in partnership with China's Tencent.
Salman Rushdie to publish first fiction book since stabbing
British-American novelist Salman Rushdie will publish his first major work of fiction since the brutal stabbing that blinded him in one eye, his publisher said on Thursday.
Six Russians dead in sinking of Egypt tourist submarine
Six Russian tourists, including two minors, died on Thursday when a submarine carrying dozens of passengers sank off a major resort town on Egypt's Red Sea coast.
Water cannon break up Indonesia military law protests
Indonesian police fired water cannons Thursday to disperse hundreds of protesters in the capital Jakarta angry at a newly passed military law, AFP reporters said.
Six dead in sinking of Egypt tourist submarine
Six people died on Thursday, two of them minors, when a tourist submarine carrying dozens of Russian visitors sank off Egypt's Red Sea coast near a major resort town.
Six dead in sinking of Egyptian tourist sub carrying Russians
Six people died on Thursday when a tourist submarine sank off Egypt's Red Sea coast, state media reported, with Russia's consulate saying 45 Russian citizens were aboard.
Israel parliament passes law enabling political control over judicial appointments
Israel's parliament on Thursday passed a law expanding elected officials' power to appoint judges, defying a years-long movement against Prime Minister Benjamin Netanyahu's contentious judicial reforms that saw massive street protests.
South Korea wildfires 'largest on record': disaster chief
Wildfires in South Korea are now "the largest on record" having burned more forest than any previous blaze, the country's disaster chief said Thursday, as the death toll rose to 26.
DEA Delays Threaten U.S. Leadership in Global Cannabis Pharma Market Despite FDA Advances
Duane Boise, CEO of MMJ International Holdings, expressed frustration over the contrasting approaches of federal agencies, stating, "While the FDA is facilitating medical innovation, the DEA's hindrance not only blocks scientific progress but also contradicts directives aimed at revitalizing domestic manufacturing." This situation starkly contrasts with the "Buy American" initiative endorsed by President Trump in 2020, which was intended to strengthen U.S. drug production capabilities and reduce dependence on foreign manufacturers.
Bausch Health to Announce First Quarter Results on April 30
LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors
MURFREESBORO, TN / ACCESS Newswire / March 27, 2025 / National Health Investors, Inc. (NYSE:NHI) (the "Company" or "NHI") announced today that Robert W. Chapin, Jr. is joining the NHI Board of Directors (the "Board") effective immediately.
CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth as consumers seek natural solutions for enhanced performance and vitality.
Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
The statistically significant responder analysis results for Mytesi® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 poster presentation at the San Antonio Breast Cancer SymposiumLate-breaker abstract recently submitted to the Multinational Association of Supportive Care in Cancer (MASCC) shows additional significant results for breast cancer subgroupThe American Cancer Society expects 316,950 new cases of breast cancer diagnosed in women in the US in 2025, and it's estimated that there were 4 million US women with a history of invasive breast cancer in 2022
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024.
Workshops and Lectures Announced for Specialty Coffee Expo 2025: Focused Hands-On Learning Across the Coffee Value Chain
Brand-New Learning Opportunities are Tailored Around Cupping and Retail Businesses